Literature DB >> 16908900

Patent nonsense: evidence tells of an industry out of social control.

Henry Mintzberg1.   

Abstract

Mesh：

Year:  2006        PMID： 16908900      PMCID： PMC1534100          DOI： 10.1503/cmaj.050575

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  12 in total

1.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  Is academic medicine for sale?

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

3.  Direct-to-consumer marketing of high-technology screening tests.

Authors:  Thomas H Lee; Troyen A Brennan
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245

4.  Prozac. A bitter pill.

Authors:  B McLean
Journal:  Fortune       Date:  2001-08-13

5.  Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.

Authors:  B B McCormick; G Tomlinson; P Brill-Edwards; A S Detsky
Journal:  JAMA       Date:  2001 Oct 24-31       Impact factor: 56.272

6.  Fewer new drugs from the pharmaceutical industry.

Authors:  David Taylor
Journal:  BMJ       Date:  2003-02-22

7.  Accountability of the pharmaceutical industry.

Authors:  M N Graham Dukes
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

Review 8.  The pharmaceutical industry as an informant.

Authors:  Joe Collier; Ike Iheanacho
Journal:  Lancet       Date:  2002-11-02       Impact factor: 79.321

Review 9.  Drug development for neglected diseases: a deficient market and a public-health policy failure.

Authors:  Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford
Journal:  Lancet       Date:  2002-06-22       Impact factor: 79.321

Review 10.  The pharmaceutical industry as a medicines provider.

Authors:  David Henry; Joel Lexchin
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321
View more
  5 in total

1.  Industrial health research in Canada.

Authors:  Yves Morin
Journal:  CMAJ       Date:  2007-06-05       Impact factor: 8.262

2.  Public/private partnerships for prescription drug coverage: policy formulation and outcomes in Quebec's universal drug insurance program, with comparisons to the Medicare prescription drug program in the United States.

Authors:  Marie-Pascale Pomey; Pierre-Gerlier Forest; Howard A Palley; Elisabeth Martin
Journal:  Milbank Q       Date:  2007-09       Impact factor: 4.911

3.  Competition in pharmaceuticals: more product- than price-oriented?

Authors:  Livio Garattini; Anna Padula
Journal:  Eur J Health Econ       Date:  2018-01

4.  Distributed Drug Discovery, Part 1: linking academia and combinatorial chemistry to find drug leads for developing world diseases.

Authors:  William L Scott; Martin J O'Donnell
Journal:  J Comb Chem       Date:  2009 Jan-Feb

5.  Patients not patents: Drug research and development as a public enterprise.

Authors:  Peter C Gøtzsche
Journal:  Eur J Clin Invest       Date:  2018-01-05       Impact factor: 4.686
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.